Bill retired from Mintz in 2026. He focused his practice on patent and trademark with a particular background in medical technology, polymers and advanced materials, polymer processing technologies, and chemicals.
viewpoints
Protecting Your Investment
January 15, 2020 | Video
Bill Geary reviews the most noteworthy IP-related investments companies make including product development and launch and acquisition or investment.
Read more
10 Millionth U.S. Patent Issues Today
June 19, 2018 | Blog
Further to our previous blog post, the U.S. Patent and Trademark Office reported that the 10 millionth patent issued today with the new patent cover design.
Read more
Fast Track Examination in the U.S. Patent and Trademark Office
April 19, 2017 | Blog
A variety of options are available to applicants to speed up patent application examination at the U.S. Patent and Trademark Office.
Read more
Preparing Your Portfolio For Prime Time: IP Due Diligence
March 23, 2016 | Article
Due diligence helps potential investors know they are making a winning bet on your start-up. Hence, investors conduct a detailed look “under the hood” of the company and the company’s IP is at center stage.
Read more
Med Tech and Biotech Entrepreneurs - $100k Challenge is OPEN for 5 More Days!
February 2, 2016 | Blog
The University of Massachusetts' Medical Device Development Center (M2D2) has launched the 5th Annual M2D2 $100K Challenge, an opportunity designed to showcase the innovative ideas and entrepreneurial spirit of seed and early-stage biotech and medical technology companies.
Read more
When Prior Terminal Disclaimers Continue to Punish Subsequent Applications: A Potential Danger in Filing an Overly-Broad Terminal Disclaimer
December 10, 2015 | Blog
A recent U.S. District Court decision has clarified a potential danger when filing terminal disclaimers that contain overly-broad language. The U.S. District Court for the Northern District of Illinois in Hagenbuch v. Sonrai Systems interpreted the terminal disclaimer language “I hereby disclaim the terminal part of any patent granted on the above-identified application or any continuation of it” as applying to any continuation application claiming priority from the application in which this terminal disclaimer was filed.
Read more
News & Press
Mintz Attorneys Recognized in Managing IP’s 2025 IP Stars
June 13, 2025|
Mintz IP Practice Recognized in 2025 IAM Patent 1000
June 2, 2025|
Mintz IP Practice Recognized in 2024 IAM Patent 1000
June 18, 2024|
One Hundred Mintz Attorneys Ranked as Leaders by Best Lawyers 2020
August 15, 2019|
Mintz Recognized by Chambers USA 2019
April 26, 2019|
Chambers USA 2018 Ranks Mintz Attorneys & Practices
May 3, 2018|
49 Mintz Attorneys Featured in Chambers USA 2016 Guide
May 31, 2016|
Events & Speaking
Nov
21
2024
BIPLA International & Medical Devices Event: Global Strategic Considerations for Medical Device Portfolios
Boston, Massachusetts
Speaker
Speaker
Moderator
Nov
13
2018
IP Strategy and Management Conference
Suffolk University Law School
Suffolk University Law School, 120 Tremont Street, Boston, MA
Panelist
Jun
25
2017
Panelist
Speaker
Speaker
Speaker
Apr
16
2015
2015 M2D2 New Venture Competition Awards
The Massachusetts Medical Device Development Center (M2D2)
One Financial Center, Boston, MA
Speaker
Read less
Mar
4
2015
